Molecular and Structural Pathology

Pedro L. Fernández Ruiz

Our group is mostly dedicated to research on biomarkers and molecular mechanisms underlying the development and progression of malignant neoplasms and we aim to provide translational knowledge to advance the diagnosis, prognosis and prediction of a variety of human cancers. For this purpose, we combine both morphological (light and ultrastructural microscopy) and advanced molecular tools including next generations sequencing (NGS), in situ hybridization and immunohistochemistry; these integrated with bioinformatics tools such as digital pathology, provide a multidisciplinary approach to cancer research. We also have a special interest, and long and productive research tradition in non-neoplastic conditions, including neurodegenerative diseases including dementias and nephropathology amongst others.

Our group of Molecular and Structural Pathology has been repeatedly recognized as a Consolidated Research Group (2017SGR639) by the Agency for Management of University and Research Grants (AGAUR) of the Government of Catalonia.

Líneas de investigación

(Publications for the Group)

1: Breast and genitourinary neoplasms

Pedro L Fernández, M. Carmen  Gómez-Plaza, Eva Castellá, Cristina Carrato

2: Lymphoid and mesenchymal  neoplasms

Gustavo Tapia, José L. Mate, Caterina Fumagalli

3: Respiratory tract, and head & neck neoplasms

José L. Mate, Alba Hernández,  Ariadna Quer

4: Digestive and hepatobiliary tract neoplasms

Raquel López, Alba Hernández, Laura Hernández, Caterina Fumagalli

5: Nervous and endocrine systems  neoplasms, and neurodegenerative disorders

Cristina Carrato, Aurelio Ariza, Katrin Beyer

6: Skin neoplasms

Ariadna Quer, Caterina Fumagalli, Paula Rodriguez

7: Nefropathology and fetal pathology

Dolores López Álvarez, Paula Rodriguez, Marta Ávila

8: Molecular Pathology

A Muñoz, Carolina Sanz

9. Paleopathology*

Pedro L Fernández

*See: Ordi J, Alonso PL, Zulueta J, Esteban J, Velasco M, Mas E, Campo E, Fernández PL. The severe gout of Holy Roman Emperor Charles V. New Engl J Med 2006; 355:516-20     

Members of the Group

Head of Service
Pedro L Fernández Ruiz  

Head of Section
José L. Mate Sanz(ELIMINAR)

Medical and Research Staff

Gustavo Tapia Melendo(ELIMINAR)
Cristina Carrato Moñino(ELIMINAR)
Aurelio Ariza Fernández(ELIMINAR)
Caterina Fumagalli(ELIMINAR)
Eva Castellá Fernández(ELIMINAR)
M. Carmen  Gómez Plaza(ELIMINAR)
Alba Hernández Gallego(ELIMINAR)
Ariadna Quer Pi-Sunyer(ELIMINAR)
Raquel López Martos (ELIMINAR)
Laura Hernández León (ELIMINAR)
Paula Rodriguez Martínez (ELIMINAR)         
Dolores López Álvarez (ELIMINAR)
Marta Ávila Terzi (ELIMINAR)           
Katrin Beyer  (ELIMINAR)   
Ana Mª Muñoz  Marmol (ELIMINAR)             
Carolina Sanz Monte(ELIMINAR)    

Research Projects

Ongoing Projects


Molecular characterization of genomics and phenotypical patterns related to resistance to neoadjuvant therapy in triple negative and Her2 positive breast carcinomas

Code: PI19/01371
Principlal Investigator: Pedro L Fernández                                                                                             
Start Date: 01/01/2020
End Date: 31/12/2022


Comprehensive molecular and microspectroscopic profiling of breast carcinomas and their resistance to neoadjuvant treatment

Code: La Marató de TV3 567/2019
Principlal Investigator: Pedro L Fernández                                                                                             
Start Date: 01/01/2020
End Date: 31/12/2022


Disclosing the transcriptome of HIV-DLBCL for targeted therapy       

Code: Becas Gilead a la investigación biomédica
Principlal Investigator: Jose Tomas Navarro                                                                                            
Start Date: 01/01/2020
End Date: 31/12/2021     

             


Análisis epigenómico integral del linfoma plasmablástico: identificación de características epigenéticas para mejorar el diagnóstico y pronóstico de los pacientes                                                  

Code: PI19/01588
Principlal Investigator: Jose Tomas Navarro                                                                                         
Start Date: 01/01/2020
End Date: 31/12/2022

   


Caracterización molecular del glioblastoma. Correlación clínico-radiológica, genómica, transcriptómica e inmunohistoquímica                           

Code: PI18/01062
Principlal Investigator:  Carmen Balaña                                                                                          
Start Date: 01/01/2019
End Date: 31/12/2021


Definición del perfil de expresión génica en biopsias renales de pacientes con obesidad mórbida y estadios precoces de glomerulopatía de la obesidad

Code: PI18/01951
Principlal Investigator: Maruja Navarro Díaz                                                                                         
Start Date: 01/01/2019
End Date: 31/12/2021


Estudio de las lesiones tuberculosas obtenidas mediante cirugía torácia: en búsqueda de los biomarcadores que mejor correlacionan con la patología, la clínica y la epidermiología

Code: PI16/01511
Principlal Investigator: Cristina Vilaplana Massaguer                                                                                        
Start Date: 01/01/2017
End Date: 31/12/2019


Més informació

Contacto

Pedro L. Fernández Ruiz

(+34) 93 497 8853

plfernandez.germanstrias(ELIMINAR)@gencat.cat